Padagis Israel Agencies

Padagis is a leading specialty pharmaceutical company focused on the development, manufacturing, and distribution of generic prescription products, with a particular leadership position in topical medicines. The company was formed in 2021 following the $1.55 billion acquisition of Perrigo Company's generic Rx division by Altaris Capital Partners. Padagis operates significant R&D and manufacturing facilities in both the United States and Israel, producing a vast portfolio of creams, ointments, gels, and oral liquids. The company specializes in complex formulations and extended-topical products, serving as a critical supplier in the dermatological, ophthalmic, and otic markets. In addition to its own product line, Padagis provides contract development and manufacturing services to global pharmaceutical partners.